Homocysteine and methylmalonic acid in Phenylketonuria patients

Abstract Hyperhomocysteinemia and vitamin B12 deficiency have been reported in patients with phenylketonuria. In this study, total homocysteine (tHcy) and methylmalonic acid (MMA) levels were analyzed in samples from 25 phenylketonuria (PKU) patients. Comparisons were made between pre- and post-trea...

Full description

Bibliographic Details
Main Authors: Giovana Regina Weber Hoss, Fernanda Sperb-Ludwig, Tássia Tonon, Soraia Poloni, Sidney Behringer, Henk J. Blom, François Maillot, Ida Vanessa Doederlein Schwartz
Format: Article
Language:English
Published: Sociedade Brasileira de Genética 2024-04-01
Series:Genetics and Molecular Biology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572023000600131&tlng=en
_version_ 1827289540045307904
author Giovana Regina Weber Hoss
Fernanda Sperb-Ludwig
Tássia Tonon
Soraia Poloni
Sidney Behringer
Henk J. Blom
François Maillot
Ida Vanessa Doederlein Schwartz
author_facet Giovana Regina Weber Hoss
Fernanda Sperb-Ludwig
Tássia Tonon
Soraia Poloni
Sidney Behringer
Henk J. Blom
François Maillot
Ida Vanessa Doederlein Schwartz
author_sort Giovana Regina Weber Hoss
collection DOAJ
description Abstract Hyperhomocysteinemia and vitamin B12 deficiency have been reported in patients with phenylketonuria. In this study, total homocysteine (tHcy) and methylmalonic acid (MMA) levels were analyzed in samples from 25 phenylketonuria (PKU) patients. Comparisons were made between pre- and post-treatment values (n= 3); on treatment values, between periods with high and normal/low phenylalanine (Phe) levels (n= 20); and in women before, during and after pregnancy (n= 3). THcy levels decreased after treating PKU with metabolic formula (p=0.014). Except for a pregnant woman before pregnancy, none of the patients had tHcy values above the normal range. In fact, tHcy was < 5 μmol/L in 34% of the samples. We observed a decrease in Phe, tHcy, and tyrosine levels during pregnancy. MMA levels did not differ significantly, with values remaining in the normal range. These data indicate that there was no B12 deficiency in patients who adhere to the diet. In conclusion, in PKU patients treated with metabolic formula, tHcy is frequently not elevated, remaining even in the lower normal range in some patients. Thus, clinical follow-up and adherence to dietary treatment are crucial to prevent B12 deficiency.
first_indexed 2024-04-24T11:51:15Z
format Article
id doaj.art-78b8aa0bac9f4db58469ead2acc98901
institution Directory Open Access Journal
issn 1678-4685
language English
last_indexed 2024-04-24T11:51:15Z
publishDate 2024-04-01
publisher Sociedade Brasileira de Genética
record_format Article
series Genetics and Molecular Biology
spelling doaj.art-78b8aa0bac9f4db58469ead2acc989012024-04-09T07:43:56ZengSociedade Brasileira de GenéticaGenetics and Molecular Biology1678-46852024-04-01463 suppl 110.1590/1678-4685-gmb-2023-0103Homocysteine and methylmalonic acid in Phenylketonuria patientsGiovana Regina Weber Hosshttps://orcid.org/0000-0003-0580-879XFernanda Sperb-Ludwighttps://orcid.org/0000-0002-2460-7064Tássia Tononhttps://orcid.org/0000-0001-8504-7526Soraia Polonihttps://orcid.org/0000-0003-4506-6487Sidney BehringerHenk J. Blomhttps://orcid.org/0000-0001-5202-9241François Maillothttps://orcid.org/0000-0002-1979-5769Ida Vanessa Doederlein Schwartzhttps://orcid.org/0000-0002-7933-6687Abstract Hyperhomocysteinemia and vitamin B12 deficiency have been reported in patients with phenylketonuria. In this study, total homocysteine (tHcy) and methylmalonic acid (MMA) levels were analyzed in samples from 25 phenylketonuria (PKU) patients. Comparisons were made between pre- and post-treatment values (n= 3); on treatment values, between periods with high and normal/low phenylalanine (Phe) levels (n= 20); and in women before, during and after pregnancy (n= 3). THcy levels decreased after treating PKU with metabolic formula (p=0.014). Except for a pregnant woman before pregnancy, none of the patients had tHcy values above the normal range. In fact, tHcy was < 5 μmol/L in 34% of the samples. We observed a decrease in Phe, tHcy, and tyrosine levels during pregnancy. MMA levels did not differ significantly, with values remaining in the normal range. These data indicate that there was no B12 deficiency in patients who adhere to the diet. In conclusion, in PKU patients treated with metabolic formula, tHcy is frequently not elevated, remaining even in the lower normal range in some patients. Thus, clinical follow-up and adherence to dietary treatment are crucial to prevent B12 deficiency.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572023000600131&tlng=enPhenylketonuriaHomocysteineMethylmalonic AcidVitamin B12
spellingShingle Giovana Regina Weber Hoss
Fernanda Sperb-Ludwig
Tássia Tonon
Soraia Poloni
Sidney Behringer
Henk J. Blom
François Maillot
Ida Vanessa Doederlein Schwartz
Homocysteine and methylmalonic acid in Phenylketonuria patients
Genetics and Molecular Biology
Phenylketonuria
Homocysteine
Methylmalonic Acid
Vitamin B12
title Homocysteine and methylmalonic acid in Phenylketonuria patients
title_full Homocysteine and methylmalonic acid in Phenylketonuria patients
title_fullStr Homocysteine and methylmalonic acid in Phenylketonuria patients
title_full_unstemmed Homocysteine and methylmalonic acid in Phenylketonuria patients
title_short Homocysteine and methylmalonic acid in Phenylketonuria patients
title_sort homocysteine and methylmalonic acid in phenylketonuria patients
topic Phenylketonuria
Homocysteine
Methylmalonic Acid
Vitamin B12
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572023000600131&tlng=en
work_keys_str_mv AT giovanareginaweberhoss homocysteineandmethylmalonicacidinphenylketonuriapatients
AT fernandasperbludwig homocysteineandmethylmalonicacidinphenylketonuriapatients
AT tassiatonon homocysteineandmethylmalonicacidinphenylketonuriapatients
AT soraiapoloni homocysteineandmethylmalonicacidinphenylketonuriapatients
AT sidneybehringer homocysteineandmethylmalonicacidinphenylketonuriapatients
AT henkjblom homocysteineandmethylmalonicacidinphenylketonuriapatients
AT francoismaillot homocysteineandmethylmalonicacidinphenylketonuriapatients
AT idavanessadoederleinschwartz homocysteineandmethylmalonicacidinphenylketonuriapatients